China Shineway Pharmaceutical Group Limited
HKSE: 2877.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhenjiang Li
- Employees
- 3,220
- Headquarters
- Shijiazhuang, China
- IPO year
- 2004
- Market cap
- HK$7.0B
- Website
- https://www.shineway.com
Loading 2877…
Loading profile data…Frequently asked questions about 2877
What does China Shineway Pharmaceutical Group Limited (2877.HK) do?
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in va...
Where does 2877.HK trade?
China Shineway Pharmaceutical Group Limited (2877.HK) trades on the Hong Kong Stock Exchange.
What sector is 2877.HK in?
China Shineway Pharmaceutical Group Limited (2877.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of China Shineway Pharmaceutical Group Limited?
Zhenjiang Li is the chief executive officer of China Shineway Pharmaceutical Group Limited (2877.HK).
Where is China Shineway Pharmaceutical Group Limited headquartered?
China Shineway Pharmaceutical Group Limited is headquartered in China.
Does 2877.HK pay a dividend?
Yes — China Shineway Pharmaceutical Group Limited (2877.HK) paid a trailing twelve-month dividend of HKD 0.61 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2877.HK go public?
China Shineway Pharmaceutical Group Limited (2877.HK) completed its initial public offering in 2004.